OpenEvidence Raises $250M, Doubles Valuation to $12B as AI Medical Platform Serves 40% of US Doctors
OpenEvidence, the AI medical platform dubbed 'ChatGPT for doctors,' raises $250 million in funding that doubles its valuation to $12 billion as the Miami-based startup now serves 40% of US physicians and generates over $100 million annually through advertising revenue.